Royal College of Surgeons in Ireland
Browse

A cross-sectional exploratory study of cardiovascular risk biomarkers in non-obese women with and without polycystic ovary syndrome: association with vitamin D

Download (1.17 MB)
journal contribution
posted on 2024-10-25, 15:38 authored by Manjula NandakumarManjula Nandakumar, Priya DasPriya Das, Thozhukat Sathyapalan, Alexandra ButlerAlexandra Butler, Stephen AtkinStephen Atkin

Vitamin D is proposed to have a protective effect against cardiovascular disease, though the mechanism is unclear. Vitamin D deficiency is common in polycystic ovary syndrome (PCOS), where it is strongly related to obesity, insulin resistance (IR) and risk of cardiovascular disease. To determine if the inherent pathophysiology of PCOS or vitamin D levels are linked to dysregulation of cardiovascular risk proteins (CVRPs), a study in non-obese women with PCOS and without IR was undertaken. Our hypothesis was that the levels of vitamin D3 and its active metabolite would be associated with CVRPs comparably in women with and without PCOS. In women with PCOS (n = 29) and controls (n = 29), 54 CVRPs were determined by Slow Off-rate Modified Aptamer (SOMA)-scan plasma protein measurement and correlated to 25-hydroxyvitamin D3 (25(OH)D3) and the active 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) measured by gold standard isotope-dilution liquid chromatography tandem mass spectrometry. Women with PCOS had comparable IR and systemic inflammation (normal C-reactive protein) to control women, though had higher free androgen index and anti-Mullerian hormone levels. 25(OH)D3 and 1,25(OH)2D3 levels did not differ between groups. Nine CVRPs were higher in PCOS (p < 0.05) (Galectin-9, Brother of CDO, C-motif chemokine 3, Interleukin-18 receptor-1, Thrombopoietin, Interleukin-1 receptor antagonist protein, Programmed cell death 1 ligand-2, Low-affinity immunoglobulin gamma Fc-region receptor II-b and human growth hormone), whilst 45 CVRPs did not differ. 25(OH)D3 correlated with five CVRPs in PCOS and one in controls (p < 0.05). Despite the women with PCOS not exhibiting overt systemic inflammation, 9 of 54 CVRPs were elevated, all relating to inflammation, and 5 of these correlated with 25(OH)D3, suggesting an ongoing underlying inflammatory process in PCOS even in the absence of obesity/IR. 

History

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors upon request.

Comments

The original article is available at https://www.mdpi.com/

Published Citation

Nandakumar M, Das P, Sathyapalan T, Butler AE, Atkin SL. A cross-sectional exploratory study of cardiovascular risk biomarkers in non-obese women with and without polycystic ovary syndrome: association with vitamin D. Int J Mol Sci. 2024;25(12):6330.

Publication Date

7 June 2024

PubMed ID

38928037

Department/Unit

  • RCSI Bahrain

Publisher

MDPI

Version

  • Published Version (Version of Record)